International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 2 : 310-312
Research Article
Risk Factors and Outcomes of Acute Kidney Injury in Critically Ill Children Admitted to the Pediatric Intensive Care Unit
 ,
 ,
 ,
 ,
Received
Jan. 11, 2026
Accepted
Feb. 25, 2026
Published
March 9, 2026
Abstract

Background: Acute Kidney Injury (AKI) is a common and severe complication among children in Pediatric Intensive Care Units (PICUs), associated with high morbidity and mortality. This study evaluates the incidence, risk factors, electrolyte imbalance, and outcomes of AKI using RIFLE and AKIN criteria.

Methods: A prospective observational study was conducted at a tertiary care center in Rajasthan, enrolling children aged 1 month to 14 years. Demographic, clinical, and laboratory data were collected, with AKI staged using both RIFLE and AKIN criteria. PRISM III scores were calculated.

Results: Of 221 children admitted to the PICU, 57 (25.7%) developed AKI. The 2–5year age group was most affected. Leading causes included sepsis (21%), dehydration (14%), and hypovolemia (12%). Electrolyte abnormalities, particularly metabolic acidosis and hyperkalemia, were common. Mortality among AKI patients was 28%. Significant predictors included sepsis, cardiac disease, younger age, and higher PRISM scores.

Conclusion: AKI significantly increases risk of mortality and hospital stay in critically ill pediatric patients. Early recognition and management of sepsis, cardiac dysfunction, and fluid-electrolyte imbalances are critical.

Keywords
INTRODUCTION

Acute Kidney Injury (AKI) is a reversible decline in renal function that frequently complicates the clinical course of critically ill pediatric patients. Its occurrence is multifactorial—triggered by sepsis, dehydration, nephrotoxic agents, and cardiovascular insufficiency. Standardized classification systems such as RIFLE and AKIN have improved AKI recognition but are underutilized in low-resource settings. Pediatric AKI is often underdiagnosed until severe due to subtle presentation and limited renal reserve in children.

 

Our study aims to analyze AKI incidence, clinical staging, biochemical derangements, and outcomes in a resource-constrained PICU. Understanding these dimensions is crucial for early identification and targeted intervention.

METHODS

This prospective observational study was conducted in the Pediatric Intensive Care Unit at Sardar Patel Medical College & PBM Hospital, Bikaner. Children aged 1 month to 14 years admitted between June 2022 and May 2023 were included, excluding those with chronic kidney disease or PICU stay <24 hours.

 

AKI diagnosis was based on RIFLE and AKIN criteria. Serum creatinine levels and urine outputs were monitored daily. Electrolytes, acid-base status, and other biochemical parameters were recorded. PRISM III scoring was performed to assess severity.

Statistical analysis was conducted using SPSS v25. Chi-square and t-tests were used for categorical and continuous variables respectively. Multivariate logistic regression was applied to identify independent predictors. P<0.05 was considered significant.

RESULTS

Out of 221 PICU admissions, 57 (25.7%) developed AKI. The most commonly affected group was 2–5 years (46%). Females (56%) were slightly more affected. Sepsis (21%) was the leading etiology, followed by gastroenteritis (14%) and hypovolemia (12%). The most frequent symptoms were decreased urine output (94.7%) and fever (77.2%). Metabolic acidosis (37%) and hyperkalemia (36%) were the most common biochemical abnormalities. Stage 3 AKIN and RIFLE-Failure stages were associated with significantly higher mortality (p<0.05).

DISCUSSION

This study highlights the high burden of AKI among children admitted to the PICU in a tertiary care hospital in Rajasthan, with an incidence of 25.7%. This aligns with studies by Mehta et al. (2007) and Akcan-Arikan et al. (2007), which identified an AKI incidence between 25–35% in critically ill pediatric patients.

 

In our study, the highest prevalence was in the 2–5-year age group. However, mortality was highest among infants under 12 months. These findings suggest that while older children are more frequently affected, infants suffer worse outcomes—likely due to developmental renal immaturity and late presentation. Rustagi et al. (2017) similarly noted increased AKI severity in younger age groups.

 

Sepsis, dehydration, and hypovolemia were the predominant causes of AKI, consistent with prior literature identifying sepsis as a leading cause of AKI in low- and middle-income countries. Sepsis contributes through multiple pathways, including renal hypoperfusion, cytokine storm, and nephrotoxic treatments.

 

Electrolyte derangements such as metabolic acidosis and hyperkalemia were frequent. These findings are important as they directly influence the risk of arrhythmia and encephalopathy. Studies by Bellomo et al. (2012) and Hoste et al. (2006) have emphasized these complications as markers of poor prognosis.

 

Mortality was significantly higher in patients with AKIN stage 3 and RIFLE-Failure/Loss classifications. These classifications were independently associated with outcomes, echoing observations by Goldstein et al. (2007), who proposed RIFLE as a valuable prognostic indicator in PICUs.

 

PRISM III scores, which assess multi-organ dysfunction, were substantially higher among non-survivors. This correlation underscores the systemic nature of AKI and supports prior studies by Joshi et al. and Uber et al. showing PRISM score's utility in PICU outcome prediction.

 

Multivariate regression showed that sepsis, cardiac disease, high PRISM III scores, and age <12 months were independent predictors of poor outcome. This emphasizes the need for comprehensive monitoring protocols and early renal function assessment in high-risk groups.

 

Although mechanical ventilation was not a statistically significant risk factor in this cohort, its association with severe AKI in other studies warrants its consideration as a confounder or co-morbidity in future analysis.

 

This study reaffirms the utility of structured AKI classification and PRISM scoring in early diagnosis and outcome prediction. It also emphasizes modifiable risk factors such as fluid management, infection control, and monitoring of nephrotoxic drugs.

CONCLUSION

AKI is a common and serious complication in pediatric intensive care, associated with increased morbidity, hospital stay, and mortality. This study reinforces the need for early detection using AKIN/RIFLE classification and clinical predictors such as PRISM scores, electrolyte imbalance, and sepsis. Implementation of strict sepsis protocols, nephrotoxin surveillance, and individualized fluid therapy may reduce AKI incidence and improve outcomes in resource-limited settings.

 

Tables and Figures

Table 1: Etiological Factors Contributing to AKI in PICU Patients

This table summarizes the primary causes of AKI observed in the study, with sepsis being the most frequent.

 

Figure 1: Distribution of AKI Stages According to AKIN Criteria

Stage 3 AKI was the most common, indicating that a significant number of children presented with advanced renal impairment.

REFERENCES
  1. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.
  2. Akcan-Arikan A, Zappitelli M, Loftis LL, et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 2007;71(10):1028-1035.
  3. Rustagi RS, et al. Risk factors and outcome of acute kidney injury in children admitted to PICU. Indian J Nephrol. 2017;27(3):207–212.
  4. Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012;380(9843):756–66.
  5. Hoste EA, et al. RIFLE criteria for acute kidney injury is associated with hospital mortality in critically ill patients. Crit Care. 2006;10(3):R73.
  6. Joshi R, et al. Role of PRISM III Score in Predicting Mortality in Pediatric Intensive Care Unit. J Pediatr Intensive Care. 2024;13(1):42–50.
  7. Uber AM, et al. Long-term sequelae of pediatric acute kidney injury. Pediatr Nephrol. 2020;35(2):271–284.
  8. Goldstein SL, et al. Pediatric patients with AKI are at higher risk for mortality than adults. Kidney Int. 2007;72(8):982–986.
Recommended Articles
Research Article Open Access
Assessment Of Knowledge, Attitude and Practice on Chronopharmacology Among the Clinical Doctors in A Tertiary Care Hospital – A Cross-Sectional Study
2026, Volume-7, Issue 2 : 650-656
Research Article Open Access
A Study of Clinical Profile and Outcome of Bronchiolitis in Children of Age 1–24 Months at A Tertiary Care Hospital in South India
2026, Volume-7, Issue 2 : 557-564
Case Report Open Access
Bullet, Blood and Airway – Gun Shot Wound Face Managed with Limited Resources
2026, Volume-7, Issue 2 : 592-596
Original Article Open Access
Morphological and Anatomical Variations of the Coronary Arteries: A Cadaveric Study
2026, Volume-7, Issue 1 : 3161-3166
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 2
Citations
31 Views
36 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved